J&J-backed Cell Therapies Developer Legend Biotech Files For Nasdaq IPO

Business - Published date: Friday May 15, 2020.

Legend Biotech, a global novel cell therapy spin-off of Hong Kong-listed biotech company GenScript Biotech, has filed f... Read more